Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A sensitive new bioassay for erythroid colony-stimulating factor

L Feldman1, K L Davis, D M Feeley

  • 1Laboratory for Cell and Molecular Biology, New England Deaconess Hospital, Harvard Medical School, Boston, MA 02215.

Experimental Hematology
|December 1, 1993
PubMed
Summary

A novel bioassay using Rauscher murine erythroleukemia cells accurately measures erythroid colony-stimulating factor (E-CSF) activity. This method quantifies E-CSF

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib.

Current oncology (Toronto, Ont.)·2018
Same author

Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims.

Epidemiology and infection·2017
Same author

The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.

Leukemia·2017
Same author

Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced Cancer.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Dose Titration, Persistence, and Adherence to Statin Therapy Among Patients with High-Risk Vascular Disease in Japan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Myelination, oligodendrocytes, and serious mental illness.

Glia·2014

Area of Science:

  • Hematology
  • Cell Biology
  • Molecular Biology

Background:

  • Erythroid colony-stimulating factor (E-CSF) is a B cell-derived protein crucial for erythroid progenitor growth.
  • Existing bioassays for E-CSF, like the bone marrow fibrin clot assay, have limitations including lengthy incubation times and reliance on accessory cells or erythropoietin (Epo).

Purpose of the Study:

  • To develop and validate a sensitive, new bioassay for measuring E-CSF activity.
  • To characterize E-CSF's proliferative effects on erythroid progenitors independently of Epo.

Main Methods:

  • Development of a bioassay utilizing 3H-thymidine incorporation into cloned Rauscher murine erythroleukemia cells.
  • Measurement of E-CSF activity in purified target cell populations, excluding endogenous growth factor-producing accessory cells.

Related Experiment Videos

  • Assay validation by measuring E-CSF from identified human cell lines and nonhuman splenic B lymphocytes.

    • Main Results:

    • The new bioassay demonstrates high sensitivity for E-CSF detection.
    • It accurately measures E-CSF's proliferative effect on erythroid progenitors within 72 to 96 hours, without Epo.
    • The assay successfully identified an E-CSF-producing human cell line and quantified E-CSF from nonhuman splenic B lymphocytes.

    Conclusions:

    • A novel Rauscher cell-based bioassay provides a sensitive and efficient method for quantifying E-CSF.
    • This assay overcomes limitations of traditional methods, enabling E-CSF measurement in purified cell populations and independently of Epo.
    • The findings facilitate further research into E-CSF's role in erythropoiesis and its potential therapeutic applications.